Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide.

Source:http://linkedlifedata.com/resource/pubmed/id/17315241

Download in:

View as

General Info

PMID
17315241